EICHORCondition: Cancer · Sponsor: EMD Serono Research & Development Institute, Inc.
Interested? Contact the study team ↓
Sponsor, CRO or site team? See where this study is running → — listed sites, countries and recruiting context. Everything below is written for patients and caregivers.
The purpose of this multi-national disease registry is to collect prospectively (with longitudinal follow-up) high-quality, standardized, and contemporaneous data to capture changes in the non-small cell lung cancer (NSCLC) treatment landscape and outcomes over time. The registry will capture data on participants; demographic, clinical characteristics (including biomarker data), treatment patterns, and effectiveness and safety outcomes for advanced NSCLC with mesenchymal-epithelial transition exon 14(METex14) participants treated with systemic therapy.
This description comes directly from the study's public registry record.
US Medical Information · 888-275-7376 · eMediUSA@emdserono.com
Communication Center · +49 6151 72 5200 · service@emdgroup.com
There is no obligation to join — the study team can answer your questions about taking part.
Always discuss trial participation with your own doctor first.
Inclusion Criteria: * Participants who signed ICF * Participants with advanced stage (stages IIIB-IV) NSCLC (all histologies) and Confirmed METex14 skipping alterations (by valid assay) * Participants who are starting or are already being treated with systemic therapy Exclusion Criteria: * Participants who are enrolled in a clinical trial
Reproduced word-for-word from the public registry record — the study team can answer questions about it.
| Holy Cross Health | Fort Lauderdale, Florida, United States | Recruiting |
| The Ohio State University Wexner Medical Center | Columbus, Ohio, United States | Recruiting |
| Vanderbilt University Medical Center | Nashville, Tennessee, United States | Active Not Recruiting |
| Klinikum Klagenfurt Am Woerthersee | Klagenfurt, Austria | Recruiting |
| Klinik Floridsdorf | Vienna, Austria | Recruiting |
| AZ Delta | Roeselare, Belgium | Recruiting |
| AZ Nikolaas | Sint-Niklaas, Belgium | Recruiting |
| Ottawa Hospital General Campus | Ottawa, Canada | Recruiting |
| Princess Margaret Cancer Centre | Toronto, Canada | Recruiting |
| British Columbia Cancer Agency (6864) | Vancouver, Canada | Recruiting |
| FN Olomouc | Olomouc, Czechia | Recruiting |
| University Hospital Na Bulovce | Prague, Czechia | Recruiting |
+ 54 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05376891